Drug intelligence / Profile preview

[18F]FEDAA1106

Development stage
Phase 1
Lead developer
Bayer
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

[18F]FEDAA1106 is a radiolabeled small molecule used as a positron emission tomography (PET) tracer for imaging the translocator protein 18 kDa (TSPO), also known as the peripheral benzodiazepine receptor. It is a highly selective and specific ligand for TSPO and enables in vivo evaluation of neuroinflammation by quantifying TSPO expression. Increased TSPO density has been observed in several neurodegenerative and psychiatric disorders. [18F]FEDAA1106 demonstrates high brain uptake and binding specificity compared to other PET tracers such as [11C]PK11195. Its primary use is research-based imaging of microglial activation and inflammation in neurological diseases[3][4][8].

Other names
N-(5-fluoro-2-phenoxyphenyl)-N-(2-fluoroethyl-5-methoxybenzyl)acetamideFedaa-1106 F-18Fedaa1106 F-18Fedaa 1106 F-18F-18 FEDAA1106F18 FEDAA1106F 18 FEDAA1106N-(5-Fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide
02

Targets

TSPO (Translocator Protein (18 kDa))

Beyond the preview

Go deeper on [18F]FEDAA1106.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [18F]FEDAA1106.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call